Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.
Wobble Genomics has raised €9.9M across 1 funding round from 5 investors, most recently a round in Mar 2024. Based in Edinburgh, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-07 | Other | €9.9M |
| BGF,EOS Advisors,IQ Capital,Mercia Ventures,Old College Capital |
| View deal → |
